These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26881708)

  • 1. Bis(thiosemicarbazone) Metal Complexes as Therapeutics for Neurodegenerative Diseases.
    Mckenzie-Nickson S; Bush AI; Barnham KJ
    Curr Top Med Chem; 2016; 16(27):3058-3068. PubMed ID: 26881708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Structural Chemistry Perspective on the Antimalarial Properties of Thiosemicarbazone Metal Complexes.
    Summers KL
    Mini Rev Med Chem; 2019; 19(7):569-590. PubMed ID: 30324878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer's Disease.
    Wasielewska JM; Szostak K; McInnes LE; Quek H; Chaves JCS; Liddell JR; Koistinaho J; Oikari LE; Donnelly PS; White AR
    ACS Chem Neurosci; 2024 Apr; 15(7):1432-1455. PubMed ID: 38477556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides and their Metal Complexes in Neurodegenerative Diseases: from Structural Studies to Nanomedicine Prospects.
    Trapani G; Satriano C; La Mendola D
    Curr Med Chem; 2018 Feb; 25(6):715-747. PubMed ID: 29076411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition metals and metal complexes in autophagy and diseases.
    Luo Y; Fu Y; Huang Z; Li M
    J Cell Physiol; 2021 Oct; 236(10):7144-7158. PubMed ID: 33694161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant properties of flavonoid metal complexes and their potential inclusion in the development of novel strategies for the treatment against neurodegenerative diseases.
    Rodríguez-Arce E; Saldías M
    Biomed Pharmacother; 2021 Nov; 143():112236. PubMed ID: 34649360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease.
    Perez LR; Franz KJ
    Dalton Trans; 2010 Mar; 39(9):2177-87. PubMed ID: 20162187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism.
    McAllum EJ; Roberts BR; Hickey JL; Dang TN; Grubman A; Donnelly PS; Liddell JR; White AR; Crouch PJ
    Neurobiol Dis; 2015 Sep; 81():20-4. PubMed ID: 25766674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal attenuating therapies in neurodegenerative disease.
    Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
    Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl- and heteroaryl-thiosemicarbazone derivatives and their metal complexes: a pharmacological template.
    Moorthy NS; Cerqueira NM; Ramos MJ; Fernandes PA
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):168-82. PubMed ID: 22963201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition metal complexes as imaging or therapeutic agents for neurodegenerative diseases.
    Ma DL; Wu C; Li G; Yung TL; Leung CH
    J Mater Chem B; 2020 Jun; 8(22):4715-4725. PubMed ID: 32100789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity of expanded coordination bis-thiosemicarbazones and copper complexes thereof.
    Akladios FN; Andrew SD; Parkinson CJ
    J Biol Inorg Chem; 2016 Dec; 21(8):931-944. PubMed ID: 27645502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause.
    Cavaleri F
    Med Hypotheses; 2015 Dec; 85(6):779-90. PubMed ID: 26604027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.
    Paterson BM; Donnelly PS
    Chem Soc Rev; 2011 May; 40(5):3005-18. PubMed ID: 21409228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.
    Wilkins HM; Morris JK
    Curr Pharm Des; 2017; 23(5):731-752. PubMed ID: 28034353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
    Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
    Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiosemicarbazones: the new wave in cancer treatment.
    Kalinowski DS; Quach P; Richardson DR
    Future Med Chem; 2009 Sep; 1(6):1143-51. PubMed ID: 21425997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.
    Liddell JR
    Neurodegener Dis Manag; 2015 Aug; 5(4):345-64. PubMed ID: 26295717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordination of Fe(III), Co(II), Ni(II), Cu(II), Zn(II), Cd(II), Hg(II), Pd(II) and Pt(II) with 2,5-hexanedione bis(thiosemicarbazone), HBTS: crystal structure of cis-[Pd(HBTS)]Cl2 and 1-(2,5-dimethyl-1H-pyrrol-yl)-thiourea.
    Jeragh B; El-Asmy AA
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():546-52. PubMed ID: 24813284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.